Sujet

CureVac GmbH in the Technology Park Tuebingen-Reutlingen

Légende

CureVac GmbH in the Technology Park Tuebingen-Reutlingen, start-up centre for biotechnology, develops vaccine against coronavirus, COVID-19 pandemic, Stuttgart, Germany, Europe

Date

2020

Crédit

Photo12/imageBROKER/Martin Storz

Notre référence

BRK20A26_124

Model release

NA

Property release

NA

Licence

Droits gérés

Format disponible

50.0Mo (2.9Mo) / 47.2cm x 26.6cm / 5574 x 3136 (300dpi)

Mots clés

Central Europe Corona Coronavirus Covid-19 Europe German Federal Republic Germany Middle Europe No People Pandemic SARS-CoV-2 South Germany Southern Germany Stuttgart Sueddeutschland architecture biotechnologies biotechnology building buildings cities city contagious contra danger of infection disease diseases epidemic health healthcare healthcare system infection infections infectious infective lab laboratories laboratory medical medical care medical cares medical technology medicine no one nobody prevention preventions research facilities research facility risk of infection risks of infections science sciences scientific scientific research sera serum sickness symbolic symbolic image symbolic picture symbolic pictures technology park vaccination vaccinations vaccine virulent virus viruses Baden-Wurttemberg Baden-Wuerttemberg building complex building complexes epidemic plague epidemic plagues provincial capital provincial capitals threat threats